Cargando…
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
BACKGROUND: The UK Medical Research Council ST03 trial compared perioperative epirubicin, cisplatin and capecitabine (ECX) chemotherapy with or without bevacizumab (B) in gastric and oesophagogastric junctional cancer. No difference in survival was noted between the arms of the trial. The present st...
Autores principales: | Allum, W. H., Smyth, E. C., Blazeby, J. M., Grabsch, H. I., Griffin, S. M., Rowley, S., Cafferty, F. H., Langley, R. E., Cunningham, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771829/ https://www.ncbi.nlm.nih.gov/pubmed/31268180 http://dx.doi.org/10.1002/bjs.11184 |
Ejemplares similares
-
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2019) -
Value of regular endosonography and [(18)F]fluorodeoxyglucose PET–CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer
por: Bjerring, O S, et al.
Publicado: (2020) -
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009) -
Carcinoma of gastro-oesophageal junction in a pregnant woman
por: Kozak, Katarzyna, et al.
Publicado: (2018) -
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
por: Cunningham, David, et al.
Publicado: (2017)